240 related articles for article (PubMed ID: 3132963)
1. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
[TBL] [Abstract][Full Text] [Related]
2. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
3. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise.
Estellés A; Tormo G; Aznar J; España F; Tormo V
Thromb Res; 1985 Nov; 40(3):373-83. PubMed ID: 4082114
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator release and plasminogen activator inhibitor levels in coronary artery disease.
Meyers DG; Haire WD; Rasmussen JK; Boyd EJ
Angiology; 1991 Jul; 42(7):561-7. PubMed ID: 1907440
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
Paramo JA; Colucci M; Collen D; van de Werf F
Br Med J (Clin Res Ed); 1985 Aug; 291(6495):573-4. PubMed ID: 3929877
[No Abstract] [Full Text] [Related]
6. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.
Jansson JH; Nilsson TK; Olofsson BO
Eur Heart J; 1991 Feb; 12(2):157-61. PubMed ID: 1904350
[TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
Auwerx J; Bouillon R; Collen D; Geboers J
Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
[TBL] [Abstract][Full Text] [Related]
9. Impaired fibrinolysis in coronary artery disease.
Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
[TBL] [Abstract][Full Text] [Related]
10. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.
Munkvad S; Gram J; Jespersen J
Eur Heart J; 1990 Jun; 11(6):525-8. PubMed ID: 2112469
[TBL] [Abstract][Full Text] [Related]
11. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity in coronary heart disease.
Yao SK; Chen ZJ; Tao SQ
Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
[TBL] [Abstract][Full Text] [Related]
13. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
Nilsson IM; Ljungnér H; Tengborn L
Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.
Mehta J; Mehta P; Lawson D; Saldeen T
J Am Coll Cardiol; 1987 Feb; 9(2):263-8. PubMed ID: 3100598
[TBL] [Abstract][Full Text] [Related]
15. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
Erickson LA; Ginsberg MH; Loskutoff DJ
J Clin Invest; 1984 Oct; 74(4):1465-72. PubMed ID: 6434594
[TBL] [Abstract][Full Text] [Related]
16. Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Daví G; Violi F; Catalano I; Giammarresi C; Putignano E; Nicolosi G; Barbagallo M; Notarbartolo A
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):41-5. PubMed ID: 1772997
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease.
García Frade LJ; Alvarez JJ; Rayo I; Torrado MC; Lasunción MA; García Avello A; Hernandez A; Marín E
Thromb Res; 1991 Aug; 63(4):407-18. PubMed ID: 1836682
[TBL] [Abstract][Full Text] [Related]
18. [Changes in plasma tissue plasminogen activator and plasminogen activator inhibitor in acute myocardial infarction and its clinical significance].
Jia HY; Chen HZ; Pu SY
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Aug; 16(4):214-6, 254. PubMed ID: 3147887
[No Abstract] [Full Text] [Related]
19. Plasminogen activator inhibitor activity as a possible indicator of disease activity in rest angina with angiographically insignificant coronary artery stenosis.
Sakata K; Kurata C; Kobayashi A; Rydzewski A; Yamazaki N
Thromb Res; 1991 Sep; 63(5):491-502. PubMed ID: 1755002
[TBL] [Abstract][Full Text] [Related]
20. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
